Davis Scott G. 4
4 · EKSO BIONICS HOLDINGS, INC. · Filed Jul 5, 2022
Insider Transaction Report
Form 4
Davis Scott G.
DirectorCEO
Transactions
- Sale
Common Stock
2022-06-30$1.72/sh−4,997$8,595→ 368,818 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person on June 30, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of a restricted stock award originally reported by the Reporting Person in Form 3 filed with the Commission on February 3, 2022
- [F2]These shares were sold in a single transaction at a price of $1.72 per share.